FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Georges Fournier

Research Profile

Disorders

Physiology

Anatomy

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Concepts & Ideas

Co-author Network

Publications

TOP 3
A Erauso; C Deruelle; L Doucet; Vincent Joulin; G Papin; M-A Perrouin-Verbe; B Rousseau; Antoine Valeri; A Volant; Georges Fournier
[Urinary continence following laparoscopic radical prostatectomy: qualitative analysis].
Olivier Cussenot; Abdel-Rahmène Azzouzi; Gladys Bantsimba-Malanda; Cecile Gaffory; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Lionel Jouffe; Morgan Roupret; Gaelle Fromont; Mathilde Sibony; Eva Comperat; Géraldine Cancel-Tassin
Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
Olivier Cussenot; Abdel-Rahmène Azzouzi; Nathalie Nicolaiew; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Géraldine Cancel-Tassin
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Georges Fournier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A Erauso; C Deruelle; L Doucet; Vincent Joulin; G Papin; M-A Perrouin-Verbe; B Rousseau; Antoine Valeri; A Volant; Georges Fournier
[Urinary continence following laparoscopic radical prostatectomy: qualitative analysis].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2012;22(15):945-53.
2008: Olivier Cussenot; Abdel-Rahmène Azzouzi; Gladys Bantsimba-Malanda; Cecile Gaffory; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Lionel Jouffe; Morgan Roupret; Gaelle Fromont; Mathilde Sibony; Eva Comperat; Géraldine Cancel-Tassin
Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5635-9.
2007: Olivier Cussenot; Abdel-Rahmène Azzouzi; Nathalie Nicolaiew; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Géraldine Cancel-Tassin
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
European urology 2007;52(4):1082-7.
2007: Olivier Cussenot; Abdel-Rahmène Azzouzi; Nathalie Nicolaiew; Gaëlle Fromont; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Stéphane Larre; Frédéric Thibault; Jean-Pierre Giordanella; Michel Pouchard; Yan Zheng; Freddie C Hamdy; Angela Cox; Géraldine Cancel-Tassin
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3596-602.
2007: Xavier Taccoen; Antoine Valeri; Jean-Luc Descotes; Vincent Morin; Eric Stindel; Laurent Doucet; Vincent Joulin; Frederic Bocqueraz; Christian Coulange; Jean-Jacques Rambeaud; Georges Fournier; Arnaud Mejean
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.
European urology 2007;51(4):980-7.
2005: Gaëlle Fromont; Laurent Chene; Michel Vidaud; Guy Vallancien; Philippe Mangin; Georges Fournier; Pierre Validire; Alain Latil; Olivier Cussenot
Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR.
International journal of cancer. Journal international du cancer 2005;114(2):174-81.
2005: Vincent Joulin; Federico Sallusto; Charles Deruelle; Xavier Taccoen; Antoine Valeri; Georges Fournier
[Idiopathic acute partial renal infarction].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2005;15(1):75-7.
2005: Jean Pierre Bercovici; Jean Fiet; Laurence Gibault; Alain Volant; Jean-Hervé Abalain; Hervé-Henri Floch; Emmanuel Sonnet; Georges Fournier
Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies).
The Journal of steroid biochemistry and molecular biology 2005;93(1):67-72.
2004: Gaëlle Fromont; Laurent Chene; Alain Latil; Ivan Bieche; Michel Vidaud; Guy Vallancien; Philippe Mangin; Georges Fournier; Pierre Validire; Olivier Cussenot
Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach.
The Journal of urology 2004;172(4 Pt 1):1382-5.
2004: Najla Amira; Géraldine Cancel-Tassin; Stéphane Bernardini; Béatrix Cochand-Priollet; Hugues Bittard; Philippe Mangin; Georges Fournier; Alain Latil; Olivier Cussenot
Expression in bladder transitional cell carcinoma by real-time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1-2: identification of 5 candidates tumor suppressor genes.
International journal of cancer. Journal international du cancer 2004;111(4):539-42.
2004: Xavier Roumier; Rahmene Azzouzi; Antoine Valéri; Francis Guillemin; Georges Fournier; Olivier Cussenot; Philippe Mangin; Luc Cormier
Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.
European urology 2004;45(3):280-5; author reply 285-6.
2003: Alain Latil; Laurent Chêne; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
The Prostate 2003;57(1):39-50.
2003: Abdel-Rahmène Azzouzi; Antoine Valeri; Luc Cormier; Georges Fournier; Philippe Mangin; Olivier Cussenot
Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.
Urology 2003;61(6):1193-7.
2003: Antoine Valeri; Laurent Briollais; Rahmene Azzouzi; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot; Florence Demenais
Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.
Annals of human genetics 2003;67(Pt 2):125-37.
2003: Alain Latil; Laurent Chêne; Béatrix Cochant-Priollet; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
Quantification of expression of netrins, slits and their receptors in human prostate tumors.
International journal of cancer. Journal international du cancer 2003;103(3):306-15.
2002: Abdel-Rahmène Azzouzi; Béatrix Cochand-Priollet; Philippe Mangin; Georges Fournier; Philippe Berthon; Alain Latil; Olivier Cussenot
Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.
European journal of endocrinology / European Federation of Endocrine Societies 2002;147(4):479-84.
2002: Antoine Valeri; Luc Cormier; Marie-Pierre Moineau; Géraldine Cancel-Tassin; Rahmene Azzouzi; Laurent Doucet; Francoise Baschet; Isabelle Cussenot; Joel L'Her; Philippe Berthon; Philippe Mangin; Olivier Cussenot; Jean-Francois Morin; Georges Fournier
Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.
The Journal of urology 2002;168(2):483-7.
2002: BENYOUSSEF NAIMI; Alain Latil; Georges Fournier; Philippe Mangin; Olivier Cussenot; Philippe Berthon
Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
The Prostate 2002;52(3):245-52.
2002: Alain Latil; Patrice Morant; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot
CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.
International journal of cancer. Journal international du cancer 2002;99(5):689-96.
2002: Luc Cormier; Francis Guillemin; Antoine Valéri; Georges Fournier; Olivier Cussenot; Philippe Mangin; Mark S Litwin
Impact of prostate cancer screening on health-related quality of life in at-risk families.
Urology 2002;59(6):901-6.
2002: Luc Cormier; Antoine Valéri; Rahmene Azzouzi; Georges Fournier; Olivier Cussenot; Philippe Berthon; Francis Guillemin; Philippe Mangin
Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
The Prostate 2002;51(4):276-85.
2001: Géraldine Cancel-Tassin; Alain Latil; Antoine Valéri; E Guillaume; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer.
International journal of cancer. Journal international du cancer 2001;93(3):455-6.
2001: Géraldine Cancel-Tassin; Alain Latil; Antoine Valéri; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
European journal of human genetics : EJHG 2001;9(2):135-42.
2000: Antoine Valeri; Rahmene Azzouzi; E Drelon; André Delannoy; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
Early-onset hereditary prostate cancer is not associated with specific clinical and biological features.
The Prostate 2000;45(1):66-71.
2000: Antoine Valeri; Georges Fournier; V Morin; J F Morin; E Drelon; Philippe Mangin; Pierre Teillac; Philippe Berthon; Olivier Cussenot
Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives.
International journal of cancer. Journal international du cancer 2000;86(6):883-7.
2000: Alain Latil; Dominique Vidaud; Antoine Valéri; Georges Fournier; M Vidaud; Rosette Lidereau; Olivier Cussenot; I Biàche
htert expression correlates with MYC over-expression in human prostate cancer.
International journal of cancer. Journal international du cancer 2000;89(2):172-6.
2000: Alain Latil; Ivan Bièche; S Pesche; Antoine Valéri; Georges Fournier; Olivier Cussenot; Rosette Lidereau
VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms.
International journal of cancer. Journal international du cancer 2000;89(2):167-71.
1999: LS Correa-Cerro; Philippe Berthon; Jürgen Häussler; Sylvia Bochum; E Drelon; Philippe Mangin; Georges Fournier; Thomas Paiss; Olivier Cussenot; Walther Vogel
Vitamin D receptor polymorphisms as markers in prostate cancer.
Human genetics 1999;105(3):281-7.
1999: Antoine Valeri; E Drelon; Thomas Paiss; Walther Vogel; Robert De Petriconi; Richard Hautmann; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot
[Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1999;9(4):680-8.
1999: Antoine Valeri; E Drelon; Rahmene Azzouzi; André Delannoy; Pierre Teillac; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot
[Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1999;9(4):672-9.
1999: Alain Latil; S Pesche; Antoine Valéri; Georges Fournier; Olivier Cussenot; Rosette Lidereau
Expression and mutational analysis of the MADR2/Smad2 gene in human prostate cancer.
The Prostate 1999;40(4):225-31.
1999: Alain Latil; Ivan Bièche; S Pesche; Alain Volant; A Valèri; Georges Fournier; Olivier Cussenot; Rosette Lidereau
Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer.
Human pathology 1999;30(7):809-15.
1999: LS Correa-Cerro; Gudrun Wöhr; Jürgen Häussler; Philippe Berthon; E Drelon; Philippe Mangin; Georges Fournier; Olivier Cussenot; Peter H Kraus; Walter Just; Thomas Paiss; J M Cantú; Walther Vogel
(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population.
European journal of human genetics : EJHG 1999;7(3):357-62.
1999: Alain Latil; S Pesche; Antoine Valeri; Olivier Cussenot; Georges Fournier; Rosette Lidereau
Common delta2 and delta8 RB1 variants in human breast and prostate tissues.
International journal of cancer. Journal international du cancer 1999;80(4):632-3.
1998: Georges Fournier; Antoine Valéri
[Treatment of metastatic prostate cancer: certainty and doubts].
Presse médicale (Paris, France : 1983) 1998;27(38):1996-2002.
1998: S Pesche; Alain Latil; F Muzeau; Olivier Cussenot; Georges Fournier; Michel Longy; C Eng; Rosette Lidereau
PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
Oncogene 1998;16(22):2879-83.
1998: Philippe Berthon; Antoine Valeri; A Cohen-Akenine; E Drelon; Thomas Paiss; Gudrun Wöhr; Alain Latil; P Millasseau; I Mellah; N Cohen; Hélène Blanché; C Bellané-Chantelot; Florence Demenais; Pierre Teillac; Alain Le Duc; Robert De Petriconi; Richard Hautmann; I Chumakov; L Bachner; NJ Maitland; Rosette Lidereau; Walther Vogel; Georges Fournier; Philippe Mangin; Olivier Cussenot
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.
American journal of human genetics 1998;62(6):1416-24.
1998: Alain Latil; Ivan Bièche; Georges Fournier; Olivier Cussenot; S Pesche; Rosette Lidereau
Molecular analysis of the FHIT gene in human prostate cancer.
Oncogene 1998;16(14):1863-8.
1998: Olivier Cussenot; Antoine Valeri; Philippe Berthon; Georges Fournier; Philippe Mangin
Hereditary prostate cancer and other genetic predispositions to prostate cancer.
Urologia internationalis 1998;60 Suppl 2():30-4; discussion 35.
1997: Alain Latil; O Cussenot; Georges Fournier; R Lidereau
Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours.
International journal of cancer. Journal international du cancer 1997;71(6):1118.
1996: Alain Latil; Georges Fournier; Olivier Cussenot; Rosette Lidereau
Differential chromosome allelic imbalance in the progression of human prostate cancer.
The Journal of urology 1996;156(6):2079-83.
1996: Olivier Cussenot; Antoine Valeri; Paul Meria; Philippe Berthon; Georges Fournier; Pierre Teillac; Alain Le Duc
[Genetic aspects in cancers of the prostate].
Pathologie-biologie 1996;44(8):737-43.
1996: Alain Latil; Olivier Cussenot; Georges Fournier; Rosette Lidereau
The BRCA2 gene is not relevant to sporadic prostate tumours.
International journal of cancer. Journal international du cancer 1996;66(2):282-3.
1996: Antoine Valeri; Philippe Berthon; Georges Fournier; J C Buzzi; L Briollais; Paul Meria; H Blanche; C Bellanne-Chantelot; Pierre Teillac; F Demenais; Philippe Mangin; N Cohen; Alain Le Duc; Olivier Cussenot
[The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1996;6(2):226-35.
1995: Alain Latil; Olivier Cussenot; Georges Fournier; J C Baron; Rosette Lidereau
Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1385-9.
1995: Alain Latil; J C Baron; Olivier Cussenot; Georges Fournier; thierry soussi; L Boccon-Gibod; Alain Le Duc; J Rouëssé; Rosette Lidereau
[Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q].
Bulletin du cancer 1995;82(7):589-97.
1995: Georges Fournier; Alain Latil; Yolande Amet; J H Abalain; A Volant; P Mangin; H H Floch; Rosette Lidereau
Gene amplifications in advanced-stage human prostate cancer.
Urological research 1995;22(6):343-7.
1994: Alain Latil; J C Baron; Olivier Cussenot; Georges Fournier; L Boccon-Gibod; Alain Le Duc; Rosette Lidereau
Oncogene amplifications in early-stage human prostate carcinomas.
International journal of cancer. Journal international du cancer 1994;59(5):637-8.
1994: E Quemener; Yolande Amet; S di Stefano; Georges Fournier; H H Floch; J H Abalain
Purification of testosterone 5 alpha-reductase from human prostate by a four-step chromatographic procedure.
Steroids 1994;59(12):712-8.
1994: E Quemener; Yolande Amet; Georges Fournier; S Di Stefano; J H Abalain; H H Floch
Glycosylated nature of testosterone 5 alpha-reductase 2 purified from human prostate.
Biochemical and biophysical research communications 1994;205(1):269-74.
1994: Alain Latil; J C Baron; Olivier Cussenot; Georges Fournier; thierry soussi; L Boccon-Gibod; Alain Le Duc; J Rouëssé; Rosette Lidereau
Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q.
Genes, chromosomes & cancer 1994;11(2):119-25.